Want to join the conversation?
$PFE's cost of sales for 2015 rose by 1% from last year. This increase was primarily due to a rise in sales volumes on inclusion of legacy Hospira operations and sales volume growth of Pfizer legacy products as well as non-recurring charges related to manufacturing plant pension obligations and inventory impairment in Venezuela in 2015.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.